Search Results
Apr 16, 2026, 10:00 ET Faculdade Engenheiro Salvador Arena, abre processo seletivo para 160 vagas gratuitas no 2º semestre de 2026
De acordo com o Ministério da Educação, por meio do Inep, apenas 27,7% das instituições de ensino superior brasileiras ficaram nas faixas 4 e 5 do IGC, ou seja, menos de um das IES alcançou os níveis considerados mais altos na avaliação federal.Em um sistema com diferenças expressivas de desempenho,
More news about: Faculdade Engenheiro Salvador Arena
Mar 16, 2026, 10:24 ET International Gate Control and AirportLabs Redefine Operational Precision at Chicago O'Hare Airport
experience.About International Gate Control (IGC) International Gate Control has provided specialized airport management services for 36 years, focusing on slot coordination, schedule facilitation, and day-of-operations management. Based in Chicago, IGC supports airport authorities and operators in
More news about: AirportLabs Limited
Mar 09, 2026, 14:15 ET L Catterton Announces Combination of Bel Cosméticos and Mundo do Cabeleireiro to Create Leading Beauty Retailer in Brazil
stake held by Vinci Compass's NEIII Fund in Mundo do Cabeleireiro.L Catterton was advised by Mattos Filho Advogados; Bel was advised by IGC Partners and VPBG Advogados; and Mundo was advised by Ártica Investimentos and Coelho & Dalle AdvogadosAbout Bel CosméticosHeadquartered
More news about: L Catterton
Mar 09, 2026, 14:15 ET L Catterton anuncia a fusão da Bel Cosméticos e do Mundo do Cabeleireiro para criar o principal varejista de beleza do Brasil
NEIII, da Vinci Compass, no Mundo do Cabeleireiro.A L Catterton foi assessorada pelo Mattos Filho Advogados, a Bel contou com assessoria da IGC Partners e do escritório VPBG Advogados, e o Mundo foi assessorado pela Ártica Investimentos e por Coelho & Dalle Advogados.Sobre a Bel
More news about: L Catterton
Mar 02, 2026, 17:46 ET Global Implanted Brain-Computer Interface Devices Market to Observe Stupendous Growth at a CAGR of ~10% by 2032 | DelveInsight
market drivers, market barriers, and key Alzheimer's disease companies, including Novo Nordisk, Eli Lilly, Suven Life Sciences, Bristol Myers Squibb, IGC Pharma, T3D Therapeutics, Lexeo Therapeutics, Axsome Therapeutics, Araclon Biotech S.L., Eisai, TauRx Therapeutics, GemVax & KAEL, AC Immune SA,
More news about: DelveInsight Business Research LLP
Feb 02, 2026, 06:55 ET 新鴻基地產旗下優質租住品牌 - TOWNPLACE 本舍 全港首推可賺取 The Point 積分
(本舍西九) 為品牌定位之作，緊靠新地西九綜合發展項目，坐擁無遮擋的維港海景，距離高鐵西九龍站僅一站之隔#，盡享瞬達大灣區核心城市的地利優勢。該旗艦項目不僅享有西九文化區的藝術氛圍，更可無縫連接新地旗下環球貿易廣場（ICC）、International Gateway Centre (IGC) 、西九藝術廣場大樓 (Artist Square Towers)，以至位於中環核心的國際金融中心（ifc）的頂級商務、購物與文化藝術體驗，代表新地對未來高端租住生活的前瞻佈局。#「一站之隔」是指由鄰近 TOWNPLACE WEST KOWLOON 本舍西九的港
More news about: 新鴻基地產
Jan 28, 2026, 17:31 ET DUB Inhibitors Market to Witness Strong Expansion Across 7MM by 2040 Driven by the Launch of Novel Therapeutics | DelveInsight
market drivers, market barriers, and key Alzheimer's disease companies, including Novo Nordisk, Eli Lilly, Suven Life Sciences, Bristol Myers Squibb, IGC Pharma, T3D Therapeutics, Lexeo Therapeutics, Axsome Therapeutics, Araclon Biotech S.L., Eisai, TauRx Therapeutics, GemVax & KAEL, AC Immune SA,
More news about: DelveInsight Business Research, LLP
Dec 26, 2025, 09:35 ET Tata Power, London School of Economics and Political Science (LSE) and International Growth Centre (IGC) launches Energy Insights and innovation lab to accelerate India's clean energy transition
Director of IGC and EEE Research Program, LSE; Dr. Jonathan Leape, Executive Director, IGC in the august presence of HM Harjinder Kang, Trade Commissioner for South Asia and British Deputy High Commissioner for Western India. Also, present at the ceremony, Dr. Chetan Ghate, Professor, ISI and IGC ISGH.The
More news about: Tata Power
Dec 09, 2025, 17:31 ET Amyotrophic Lateral Sclerosis Market Outlook: Expanding Therapeutic Pipeline and Novel Drug Launches Propel Growth Throughout Forecast Period (2025-2034) | DelveInsight
market drivers, market barriers, and key Alzheimer's disease companies, including Novo Nordisk, Eli Lilly, Suven Life Sciences, Bristol Myers Squibb, IGC Pharma, T3D Therapeutics, Lexeo Therapeutics, Axsome Therapeutics, Araclon Biotech S.L., Eisai, TauRx Therapeutics, GemVax & KAEL, AC Immune SA,
More news about: DelveInsight Business Research, LLP
Nov 06, 2025, 08:00 ET The International Gifted Consortium (IGC), Research Center for Highly--Profoundly Gifted marks 10-years of global impact and launches search for legacy donors
President of IGC. "We are calling on visionary donors to step forward now — to become the namesake of the IGC Research Center and ensure that generations of gifted youth receive the support they urgently need." Global Collaboration, Local Impact IGC collaborations
More news about: The International Gifted Consortium (IGC), Research Center for Highly-Profoundly Gifted
Sep 18, 2025, 17:31 ET NF-κB Inhibitors Market to Witness Accelerated Expansion Across the 7MM through 2034 | DelveInsight
Inc., Araclon Biotech S.L., Eisai Co., Ltd., TauRx Therapeutics, TrueBinding, Inc., AC Immune SA, Johnson & Johnson, Longeveron Inc., Vaccinex Inc., IGC Pharma LLC, among others.
More news about: DelveInsight Business Research, LLP
Sep 18, 2025, 03:47 ET PotisEdge and FK Power Announce Strategic Collaboration to Advance North American Energy Market Initiatives
upfront cost, rapid deployment, and a revenue-sharing model for commercial property owners. FK Power represents a collaboration among SolarMax, IGC, and Meter, with key partners PotisEdge and Terahiv. Together, the team aims to transform EV infrastructure through flexible deployment and intelligent
More news about: PotisEdge
Sep 05, 2025, 05:00 ET GLP-1 Agonists Market to Show Impressive Growth at a CAGR of 10.8% During the Forecast Period (2025-2034) | DelveInsight
Inc., Araclon Biotech S.L., Eisai Co., Ltd., TauRx Therapeutics, TrueBinding, Inc., AC Immune SA, Johnson & Johnson, Longeveron Inc., Vaccinex Inc., IGC Pharma LLC, among others. About DelveInsight DelveInsight is a leading Business Consultant and Market Research firm focused
More news about: DelveInsight Business Research, LLP
Aug 28, 2025, 17:31 ET GSK 3 Inhibitor Market Landscape Shows Promising Upswing as Growing Interest in Targeted Therapies | DelveInsight
Inc., Araclon Biotech S.L., Eisai Co., Ltd., TauRx Therapeutics, TrueBinding, Inc., AC Immune SA, Johnson & Johnson, Longeveron Inc., Vaccinex Inc., IGC Pharma LLC, among others.
More news about: DelveInsight Business Research, LLP
Aug 07, 2025, 17:31 ET Progressive Supranuclear Palsy Market on Upward Trajectory During the Forecast Period (2025-2034) with Emerging Immunotherapies | DelveInsight
Inc., Araclon Biotech S.L., Eisai Co., Ltd., TauRx Therapeutics, TrueBinding, Inc., AC Immune SA, Johnson & Johnson, Longeveron Inc., Vaccinex Inc., IGC Pharma LLC, among others.
More news about: DelveInsight Business Research, LLP
Jul 28, 2025, 17:31 ET Alpha-synuclein Inhibitors Market to Witness Strong CAGR Through 2034, Driven by Advances in Neurodegenerative Therapies | DelveInsight
Inc., Araclon Biotech S.L., Eisai Co., Ltd., TauRx Therapeutics, TrueBinding, Inc., AC Immune SA, Johnson & Johnson, Longeveron Inc., Vaccinex Inc., IGC Pharma LLC, among others.
More news about: DelveInsight Business Research, LLP
Jul 10, 2025, 17:46 ET Comprehensive Lewy Body Dementia Market Analysis of Evolving Trends and Anticipated Growth Trajectory During the Forecast Period (2025-2034) | DelveInsight
Inc., Araclon Biotech S.L., Eisai Co., Ltd., TauRx Therapeutics, TrueBinding, Inc., AC Immune SA, Johnson & Johnson, Longeveron Inc., Vaccinex Inc., IGC Pharma LLC, among others.
More news about: DelveInsight Business Research, LLP
Jul 01, 2025, 17:46 ET NADPH Oxidase (NOX)-Replacement Therapies Market to Observe Stunning Growth During the Forecast Period (2025-2034) Across 7MM | DelveInsight
Inc., Araclon Biotech S.L., Eisai Co., Ltd., TauRx Therapeutics, TrueBinding, Inc., AC Immune SA, Johnson & Johnson, Longeveron Inc., Vaccinex Inc., IGC Pharma LLC, among others.
More news about: DelveInsight Business Research, LLP
Jul 01, 2025, 17:31 ET Frontotemporal Dementia Market Sees Rise in Precision Medicine and Gene Therapy Approaches | DelveInsight
Inc., Araclon Biotech S.L., Eisai Co., Ltd., TauRx Therapeutics, TrueBinding, Inc., AC Immune SA, Johnson & Johnson, Longeveron Inc., Vaccinex Inc., IGC Pharma LLC, among others.
More news about: DelveInsight Business Research, LLP